America’s first CRISPR trial is still nearly 100% effective 3 years on

6Report
America’s first CRISPR trial is still nearly 100% effective 3 years on

Incredible new data has revealed an experimental CRISPR gene editing therapy is both safe and effective up to three years after treatment. The results come from one of the longest running trials using CRISPR to treat a pair of rare blood diseases.

Similar news

Share
Report

Report this article here.